Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Suvmax in 18-Fluorodeoxyglucose PET/CT Potentially Predict the Estimation of a Positive Biopsy in Cases of Lymphoma

Pooja Chandra, Olufunke Akinbobuyi, Albert Liao, Jyoti Arora, MS, Zhengjia Chen, Mary J Lechowicz, MD, Amelia A. Langston, Jeanne Kowalsky, PhD, Jonathon B. Cohen, MD, Christopher R Flowers, Leon Bernal-Mizrachi, MD

Blood (2015) 126 (23): 5043.

https://doi.org/10.1182/blood.V126.23.5043.5043

Published: 2015

Journal Articles

Complex Karyotype in Mantle Cell Lymphoma (MCL) Is Associated with Inferior Progression-Free Survival in Patients (pts) Receiving R-Hypercvad Followed By Autologous Stem Cell Transplant

Michael Jinpyo Lee, B.S., Jeffrey Switchenko, PhD, Janeen S Thomas, Jean L. Koff, MD, Loretta Nastoupil, MD, Mary Jo Lechowicz, MD, Amelia A Langston, MD, Christopher Flowers, MD, Jonathon B. Cohen, MD

Blood (2015) 126 (23): 5095.

https://doi.org/10.1182/blood.V126.23.5095.5095

Published: 2015

Journal Articles

Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

Blood (2011) 117 (12): 3294–3301.

https://doi.org/10.1182/blood-2010-08-301796

Published: 2011

Journal Articles

Reduced Intensity Conditioning with Allogeneic Hematopoietic Cell Transplantation for the Treatment of High-Risk Acute Lymphoblastic Leukemia.

Ron Ram, MD, Rainer F. Storb, MD, David G. Maloney, MD, Brenda M. Sandmaier, MD, Michael Maris, MD, Judith Shizuru, MD, PhD, Thomas Chauncey, MD, PhD, Amelia A. Langston, MD, George E. Georges, MD

Blood (2009) 114 (22): 1210.

https://doi.org/10.1182/blood.V114.22.1210.1210

Published: 2009

Journal Articles

Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse.

Blood (2009) 114 (22): 788.

https://doi.org/10.1182/blood.V114.22.788.788

Published: 2009

Journal Articles

Anti-Viral Immunity to CMV Reactivation in Allogeneic HSCT Recipients.

Mohammad S Hossain, PhD, Wayne A Harris, Sarah W Myers, Mojtaba Akhtari, MD, Amelia A Langston, MD, Edmund K. Waller, MD, PhD

Blood (2009) 114 (22): 1165.

https://doi.org/10.1182/blood.V114.22.1165.1165

Published: 2009

Journal Articles

Ara-C, Topotecan, and Gemtuzumab Ozogamicin [ATGO] Is An Effective Induction Regimen for Advanced MDS and Secondary or Relapsed AML: Analysis of a Phase I/II Study

Amelia A Langston, MD, Sujatha Murali, MD, Stephanie McMillan, RN, Leonard T. Heffner, MD, Sagar Lonial, MD, Edmund K. Waller, MD, PhD, Christopher R. Flowers, MD, Jonathan Kaufman, MD, Morgan L. McLemore, MD, Rajni Sinha, MD, Mary J Lechowicz, MD, H. Jean Khoury, MD, Elliott F. Winton, MD

Blood (2008) 112 (11): 3644.

https://doi.org/10.1182/blood.V112.11.3644.3644

Published: 2008

Journal Articles

Higher Numbers of Circulating Dendritic Cells and T-Cells Predict Response to Extracorporeal Photopheresis in Patients with Chronic Graft-Versus-Host Disease

Cynthia R. Giver, PhD, Mojtaba Akhtari, MD, Amelia A. Langston, MD, H. Jean Khoury, MD, Christopher R. Flowers, MD, Jonathan L. Kaufman, MD, Sagar Lonial, MD, Mary J. Lechowicz, MD, Charise L. Gleason, NP, M. Louette Vaughn, RN, Edmund K. Waller, MD, PhD

Blood (2008) 112 (11): 1183.

https://doi.org/10.1182/blood.V112.11.1183.1183

Published: 2008

Journal Articles

Allogeneic Hematopoietic Cell Transplantation (HCT) after Nonmyeloablative Conditioning for Patients (pts) Aged ≥60 Years.

Blood (2008) 112 (11): 2162.

https://doi.org/10.1182/blood.V112.11.2162.2162

Published: 2008

Journal Articles

Sustained Graft-Versus-Lymphoma Effect among Patients (pts) with Mantle Cell Lymphoma (MCL) Given Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT).

Mohamed L. Sorror, MD, MS, Barry Storer, PhD, Brenda M. Sandmaier, MD, Michael Maris, MD, Thomas Chauncey, MD, Richard T. Maziarz, MD, Michael Pulsipher, MD, Judith Shizuru, MD, PhD, Dietger Niederwieser, MD, Edward Agura, MD, James C. Wade, MD, MPH, Amelia A Langston, MD, Rainer F. Storb, MD, David G. Maloney, MD, PhD

Blood (2008) 112 (11): 2147.

https://doi.org/10.1182/blood.V112.11.2147.2147

Published: 2008

Journal Articles

The Effect of Rituximab on Mobilization with AMD3100 Plus G-CSF in Patients with Relapsed or Refractory NHL or HD.

Jonathan L. Kaufman, MD, Amanda M. Cook, CCRP, Christopher Flowers, MD, Amelia A. Langston, MD, Sagar Lonial, MD, Mary Jo Lechowicz, MD, H. Jean Khoury, MD, Gary Calandra, MD, Ned Waller, MD, PhD

Blood (2007) 110 (11): 1912.

https://doi.org/10.1182/blood.V110.11.1912.1912

Published: 2007

Journal Articles

A Randomized Phase I Trial of Melphalan + Bortezomib as Conditioning for Autologous Transplant for Myeloma: The Effect of Sequence of Administration.

Sagar Lonial, MD, Jonathan Kaufman, MD, Amelia A. Langston, MD, Leonard T. Heffner, MD, Claire Torre, Mary J. Lechowicz, MD, Christopher Flowers, MD, Stephanie McMillan, RN, Michael Arnold, Ned K. Waller, MD, PhD

Blood (2007) 110 (11): 949.

https://doi.org/10.1182/blood.V110.11.949.949

Published: 2007

Journal Articles

A Randomized Trial To Evaluate the Impact of Cytokines (G-CSF or GM + G-CSF) on Dendritic Cell and T-Cell Content and Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant.

Sagar Lonial, MD, Stephanie McMillan, Claire Torre, Amelia A. Langston, MD, Ellie Hamilton, Amanda Cook, Christopher Flowers, MD, Jonathan L. Kaufman, MD, Mary Jo Lechowicz, MD, Ned Waller, MD

Blood (2006) 108 (11): 3377.

https://doi.org/10.1182/blood.V108.11.3377.3377

Published: 2006

Journal Articles

T Cell Reconstitution in First 200 Days Post Transplantation Predicts Long Term Survival in Allogeneic Hematopoetic Progenitor Cell Transplantation (HPCT).

Laura Vann, Milcah Larks, MD, Christopher Flowers, MD, Sagar Lonial, MD, Jonathan Kaufman, MD, Mary Jo Lechowicz, MD, Amelia A. Langston, MD, Jean Khoury, MD, Ned Waller, MD,PhD

Blood (2006) 108 (11): 3224.

https://doi.org/10.1182/blood.V108.11.3224.3224

Published: 2006

Journal Articles

Efficacy and Safety of Posaconazole (POS) in the Treatment of Refractory Invasive Fungal Infections (rIFIs) in Patients with Underlying Renal Impairment.

Amelia A. Langston, MD, Donald R. Graham, MD, J. Richard Graybill, MD, Lisa D. Pedicone, PhD, Issam I. Raad, MD

Blood (2005) 106 (11): 5380.

https://doi.org/10.1182/blood.V106.11.5380.5380

Published: 2005

Journal Articles

Allogeneic Hematopoietic Cell Transplantation (HCT) after Nonmyeloablative Conditioning for Relapsed or Refractory Follicular Lymphoma.

Michael B. Maris, MD, Brenda M. Sandmaier, MD, Barry Storer, PhD, Edward Agura, MD, James Wade, MD, Richard T. Maziarz, MD, Stephen Forman, MD, Judy Shizuru, MD, PhD, Thomas Chauncey, MD, PhD, Christoph Kahl, MD, Amelia A. Langston, MD, Dietger Niederwieser, MD, Rainer Storb, MD, David G. Maloney, MD

Blood (2005) 106 (11): 1130.

https://doi.org/10.1182/blood.V106.11.1130.1130

Published: 2005

Journal Articles

A Randomized Trial To Evaluate the Impact of Cytokines (G-CSF or GM + G-CSF) on Dendritic Cell and T-Cell Content and Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant.

Sagar Lonial, MD, Claire Torre, Amelia A. Langston, MD, Stephanie McMillan, Ellie Hamilton, Christopher Flowers, MD, Mary J. Lechowicz, MD, Edmund K. Waller, MD, PhD

Blood (2005) 106 (11): 1960.

https://doi.org/10.1182/blood.V106.11.1960.1960

Published: 2005

Journal Articles

Relapse Free Survival of Elderly AML Patients Is Comparable to That of Younger Adults When Treated with a Modified Dose Intensive Cytarabine Regimen.

Amelia A. Langston, MD, Leonard T. Heffner, MD, Donald Hutcherson, RPh, Jessica Neely, MS, Christopher Flowers, MD, MS, Edmund K. Waller, MD, PhD, Sagar Lonial, MD, Hanna J. Khoury, MD, Elliot Winton, MD

Blood (2005) 106 (11): 4634.

https://doi.org/10.1182/blood.V106.11.4634.4634

Published: 2005

Journal Articles

Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma

Michael B. Maris, Brenda M. Sandmaier, Barry E. Storer, Thomas Chauncey, Monic Jain Stuart, Richard T. Maziarz, Edward Agura, Amelia A. Langston, Michael Pulsipher, Rainer Storb, David G. Maloney

Blood (2004) 104 (12): 3535–3542.

https://doi.org/10.1182/blood-2004-06-2275

Published: 2004

Journal Articles

A Randomized Trial to Evaluate the Impact of Cytokines on Dendritic Cell, T-Cell and T-Cell Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant: An Interim Analysis.

Sagar Lonial, MD, Claire Torre, Michelle Hicks, Stephanie Mcmillan, Amelia A. Langston, MD, Christopher R. Flowers, MD, Mary J. Lechowicz, MD, Edmund K. Waller, MD, PhD

Blood (2004) 104 (11): 2854.

https://doi.org/10.1182/blood.V104.11.2854.2854

Published: 2004

NARROW

Suvmax in 18-Fluorodeoxyglucose PET/CT Potentially Predict the Estimation of a Positive Biopsy in Cases of Lymphoma

Complex Karyotype in Mantle Cell Lymphoma (MCL) Is Associated with Inferior Progression-Free Survival in Patients (pts) Receiving R-Hypercvad Followed By Autologous Stem Cell Transplant

Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

Reduced Intensity Conditioning with Allogeneic Hematopoietic Cell Transplantation for the Treatment of High-Risk Acute Lymphoblastic Leukemia.

Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse.

Anti-Viral Immunity to CMV Reactivation in Allogeneic HSCT Recipients.

Ara-C, Topotecan, and Gemtuzumab Ozogamicin [ATGO] Is An Effective Induction Regimen for Advanced MDS and Secondary or Relapsed AML: Analysis of a Phase I/II Study

Higher Numbers of Circulating Dendritic Cells and T-Cells Predict Response to Extracorporeal Photopheresis in Patients with Chronic Graft-Versus-Host Disease

Allogeneic Hematopoietic Cell Transplantation (HCT) after Nonmyeloablative Conditioning for Patients (pts) Aged ≥60 Years.

Sustained Graft-Versus-Lymphoma Effect among Patients (pts) with Mantle Cell Lymphoma (MCL) Given Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT).

The Effect of Rituximab on Mobilization with AMD3100 Plus G-CSF in Patients with Relapsed or Refractory NHL or HD.

A Randomized Phase I Trial of Melphalan + Bortezomib as Conditioning for Autologous Transplant for Myeloma: The Effect of Sequence of Administration.

A Randomized Trial To Evaluate the Impact of Cytokines (G-CSF or GM + G-CSF) on Dendritic Cell and T-Cell Content and Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant.

T Cell Reconstitution in First 200 Days Post Transplantation Predicts Long Term Survival in Allogeneic Hematopoetic Progenitor Cell Transplantation (HPCT).

Efficacy and Safety of Posaconazole (POS) in the Treatment of Refractory Invasive Fungal Infections (rIFIs) in Patients with Underlying Renal Impairment.

Allogeneic Hematopoietic Cell Transplantation (HCT) after Nonmyeloablative Conditioning for Relapsed or Refractory Follicular Lymphoma.

A Randomized Trial To Evaluate the Impact of Cytokines (G-CSF or GM + G-CSF) on Dendritic Cell and T-Cell Content and Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant.

Relapse Free Survival of Elderly AML Patients Is Comparable to That of Younger Adults When Treated with a Modified Dose Intensive Cytarabine Regimen.

Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma

A Randomized Trial to Evaluate the Impact of Cytokines on Dendritic Cell, T-Cell and T-Cell Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant: An Interim Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only